Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1987 Oct;46(10):773–776. doi: 10.1136/ard.46.10.773

A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

J C Edwards 1, M L Snaith 1, D A Isenberg 1
PMCID: PMC1003386  PMID: 3318723

Abstract

Twenty one patients with severe systemic lupus erythematosus (SLE) were treated with three daily infusions of either 100 mg or 1 g of methylprednisolone on a randomised double blind basis. Nine patients with unsatisfactory outcome subsequently received the alternative therapy. Patients were rated for improvement on a four point scale using individualised criteria. On three occasions patients improved to 'ideal', on 12 there was 'useful' improvement, on 11 the patient remained static, and on four occasions there was deterioration. There was no significant difference between the clinical states after the two doses. The results suggest that any additional benefit of 1 g of methylprednisolone over 100 mg by repeated infusion in the treatment of active SLE is probably not enough to justify the potential hazards and cost involved.

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bocanegra T. S., Castañeda M. O., Espinoza L. R., Vasey F. B., Germain B. F. Sudden death after methylprednisolone pulse therapy. Ann Intern Med. 1981 Jul;95(1):122–122. doi: 10.7326/0003-4819-95-1-122_1. [DOI] [PubMed] [Google Scholar]
  2. Cathcart E. S., Idelson B. A., Scheinberg M. A., Couser W. G. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976 Jan 24;1(7952):163–166. doi: 10.1016/s0140-6736(76)91272-1. [DOI] [PubMed] [Google Scholar]
  3. Dosa S., Cairns S. A., Lawler W., Mallick N. P., Slotki I. N. The treatment of lupus nephritis by methyl prednisolone pulse therapy. Postgrad Med J. 1978 Sep;54(635):628–632. doi: 10.1136/pgmj.54.635.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eyanson S., Passo M. H., Aldo-Benson M. A., Benson M. D. Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis. 1980 Aug;39(4):377–380. doi: 10.1136/ard.39.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fessel W. J. Megadose corticosteroid therapy in systemic lupus erythematosus. J Rheumatol. 1980 Jul-Aug;7(4):486–500. [PubMed] [Google Scholar]
  6. Freedman M. D., Schocket A. L., Chapel N., Gerber J. G. Anaphylaxis after intravenous methylprednisolone administration. JAMA. 1981 Feb 13;245(6):607–608. [PubMed] [Google Scholar]
  7. Isenberg D. A., Morrow W. J., Snaith M. L. Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis. 1982 Aug;41(4):347–351. doi: 10.1136/ard.41.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liebling M. R., Leib E., McLaughlin K., Blocka K., Furst D. E., Nyman K., Paulus H. E. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med. 1981 Jan;94(1):21–26. doi: 10.7326/0003-4819-94-1-21. [DOI] [PubMed] [Google Scholar]
  9. Liebling M. R., McLaughlin K., Boonsue S., Kasdin J., Barnett E. V. Monthly pulses of methylprednisolone in SLE nephritis. J Rheumatol. 1982 Jul-Aug;9(4):543–548. [PubMed] [Google Scholar]
  10. Lurie D. P., Kahaleh M. B. Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus. J Rheumatol. 1982 Mar-Apr;9(2):311–314. [PubMed] [Google Scholar]
  11. Moses R. E., McCormick A., Nickey W. Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med. 1981 Dec;95(6):781–782. doi: 10.7326/0003-4819-95-6-781_3. [DOI] [PubMed] [Google Scholar]
  12. Neild G. H., Lee H. A. Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa. Postgrad Med J. 1977 Jul;53(621):382–387. doi: 10.1136/pgmj.53.621.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Newmark K. J., Mitra S., Berman L. B. Letter: Acute arthralgia following high-dose intravenous methylprednisolone therapy. Lancet. 1974 Jul 27;2(7874):229–229. doi: 10.1016/s0140-6736(74)91539-6. [DOI] [PubMed] [Google Scholar]
  14. Suchman A. L., Condemi J. J., Leddy J. P. Seizure after pulse therapy with methyl prednisolone. Arthritis Rheum. 1983 Jan;26(1):117–117. doi: 10.1002/art.1780260123. [DOI] [PubMed] [Google Scholar]
  15. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES